Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to take part and have signed a consent form agreeing to participate in the study.
- You are a female between 18 and 70 years old.
- You have been diagnosed with early-stage breast cancer (stages I to IIIA) that can be treated with surgery, your tumor is at least 2cm in size as shown on an MRI scan, and the cancer has not spread to other parts of the body. If there are multiple tumors, the largest one must be at least 2cm.
- You are generally well enough to carry out daily activities with little or no limitation (confirm with trial site).
- Your liver and kidney are working well enough, based on blood test results that fall within acceptable ranges (confirm with trial site).
Who may not be able to join:
- You have already received treatment for your breast cancer before joining the trial.
- Your breast cancer is at an advanced stage where surgery is not possible, or you have a type called inflammatory breast cancer.
- You have cancer in both breasts.
- You have multiple tumors spread across different areas (quadrants) of the same breast.
- You are not considered a suitable candidate for chemotherapy given before surgery (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jian Huang, 2 nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Phone: +8657189713716
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Correlation between drug sensitivity test results in patient-derived organoid models and clinical outcomes.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.